This updated rapid risk assessment was prepared jointly with the Robert Koch Institute (RKI), Germany, and the National Institute of Public Health and the Environment (RIVM), Netherlands. Epidemiological and microbiological studies conducted by the Robert Koch Institute (RKI) in Germany and the National Institute of Public Health and the Environment (RIVM) in the Netherlands have confirmed that the zoonotic potential of SBV is absent or very low. ECDC fully supports the assessments results delivered by RIVM and RKI, which both conclude that it is very unlikely that SBV poses a risk to humans.